Immunodeficiency Conditions 2024 PDF

Document Details

FlatteringOctagon

Uploaded by FlatteringOctagon

Petre Shotadze Tbilisi Medical Academy

2024

Liza Peikrishvili

Tags

immunodeficiency medical conditions genetic disorders health

Summary

These lecture notes cover different types of immunodeficiency conditions, including their classifications, characteristics, and treatment options. The document discusses genetic and secondary immunodeficiencies, and provides details on specific disorders, such as X-linked agammaglobulinemia and Wiskott-Aldrich syndrome.

Full Transcript

Immunodeficiency conditions Liza Peikrishvili 2024 Immunodeficiency conditions - classification Immunodeficiency conditions - classification Immunodeficiencies can also be divided into primary (usually genetic) and secondary, where the immune defect is caused by some othe...

Immunodeficiency conditions Liza Peikrishvili 2024 Immunodeficiency conditions - classification Immunodeficiency conditions - classification Immunodeficiencies can also be divided into primary (usually genetic) and secondary, where the immune defect is caused by some other nonimmunological disease. Immunodeficiency conditions - classification Immunodeficiencies are divided into those of the specific immune system (e.g. T cells or B cells) or those of the innate or nonspecific immune system (e.g. complement and neutrophils). Immunodeficiency conditions - classification 1. Antibody (B cells) immunodeficiency diseases, for example, congenital, X-linked (Bruton's) agammaglobulinemia 2. Cellular (T cell) immunodeficiency diseases, for example, AIDS (helper T cell deficiency) 3. Combined antibody-mediated (B cell) and cell-mediated (T cell) immunodeficiency, for example, severe combined immunodeficiency disease Disorders of Chemotaxis 1. Wiskott-Aldrich syndrome 2. Phagocytic dysfunction diseases, for example, chronic granulomatous disease 3. Complement abnormalities in immunodeficiency diseases, for example, C3 deficiency Clinical features of immunodeficiency X-linked agammaglobulinaemia (Bruton’s disease)  This was the first immunodeficiency to be described (1952). It has an incidence of 1 in 100 000–200 000 and a prevalence of 1 in 10 000  Genetic disorder due to a mutations on the X chromosome affecting the btk gene (Bruton agammaglobulinemia tyrosine kinase) - Gene is located at Xq21.3–22  Defects in the gene prevent B-cell maturation from pro-B-cell to pre-B-cell https://www.youtube.com/watch?v=87pJDxNI-2U X-linked agammaglobulinaemia (Bruton’s disease) X-linked agammaglobulinaemia (Bruton’s disease) Presentation  Usually early in childhood, after 6 months of age, when maternal antibody has largely disappeared  Recurrent infections of lungs and ears (children of this age don’t have sinuses): Haemophilus influenzae and pneumococci (upper and lower respiratory tract, meningitis) meningococcus (meningitis) Staphylococci (septic arthritis) Giardia Salmonella Campylobacter infections of the gut Rarely Pneumocystis Milder phenotypes may present later X-linked agammaglobulinaemia (Bruton’s disease) Diagnosis  Manifested in males  Bacterial infection  B cells are low or absent  IgG ↓↓  T-cell numbers and function are normal  NK-cell numbers and function are normal X-linked agammaglobulinaemia (Bruton’s disease) - treatment  IV IgG should be started at the earliest opportunity at a dose of 200–600mg/kg/month given at intervals of 2–3 weeks Longer intervals do not give satisfactory replacement  Subcutaneous immunoglobulin given weekly (same total dose) is an alternative  Prompt antibiotic therapy (course of 10–14 days) for upper and lower respiratory tract infections  Prophylactic azithromycin 3x/week 9 carbocisteine - where there is established bronchiectasis  Long-term immunological follow-up (plus additional specialist input as required). Wiskott–Aldrich syndrome (WAS) Wiskott–Aldrich syndrome is an X-linked disorder causing thrombocytopenia with small platelets, eczema, and a progressive immune deficiency The same gene is also responsible for X-linked thrombocytopenia, a milder variant in which the eczema and immune deficiency are absent, and X-linked neutropenia Wiskott–Aldrich syndrome (WAS)  X-linked disease  The gene is located at Xp11.23 encoding WASP (Wiskott–Aldrich-associated protein) https://www.youtube.com/watch?v=R5ADKNVc6t4 Wiskott–Aldrich syndrome (WAS) Wiskott–Aldrich syndrome (WAS) Wiskott–Aldrich syndrome (WAS) Presentation  Early childhood - in males with severe eczema, which has an atypical distribution compared with atopic eczema  Eczematous skin  Abnormal bleeding is due to the low platelet count, and bleeding  Infections develop more gradually, usually affecting the respiratory tract, and are bacterial  Opportunist infections: Pneumocystis, disseminated molluscum contagiosum, papillomavirus, systemic varicella, herpes simplex, and CMV  Fungal infections are uncommon, and are mainly Candida  Inflammatory bowel disease  Family history Wiskott–Aldrich syndrome (WAS) Wiskott–Aldrich syndrome (WAS) Wiskott–Aldrich syndrome (WAS) Diagnosis  Clinical features: there is thrombocytopenia (variable in range

Use Quizgecko on...
Browser
Browser